West Pharmaceutical Services Reports Q3 2026 Revenue of $874.5M, EPS of $3.02
Third-quarter net income was $214 million. Revenue increased 8.7% and net income rose 52.9% from the prior-year quarter.
West Pharmaceutical Services reported third-quarter 2026 revenue of $874.5 million and net income of $214 million, with diluted EPS of $3.02. Revenue increased 8.7% and net income rose 52.9% from the prior-year quarter.Financial Highlights¹ Reported as “Net sales”. ² Reported as “Net income”. ³ Rep…